These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36203031)

  • 41. Comparison of different bridging anticoagulation therapies used after mechanical heart valve replacement in Chinese patients - a prospective cohort study.
    Li BX; Liu SD; Qi L; Sun S; Sun W; Li YM; Song B; Wu XA
    J Cardiothorac Surg; 2020 Feb; 15(1):40. PubMed ID: 32093747
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Optimal timing of initiation of thromboprophylaxis in spine trauma managed operatively: A nationwide propensity-matched analysis of trauma quality improvement program.
    Zeeshan M; Khan M; O'Keeffe T; Pollack N; Hamidi M; Kulvatunyou N; Sakran JV; Gries L; Joseph B
    J Trauma Acute Care Surg; 2018 Aug; 85(2):387-392. PubMed ID: 29613956
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Optimal Timing of Initiation of Thromboprophylaxis after Nonoperative Blunt Spinal Trauma: A Propensity-Matched Analysis.
    Khan M; Jehan F; O'Keeffe T; Hamidi M; Truitt M; Zeeshan M; Gries L; Tang A; Joseph B
    J Am Coll Surg; 2018 May; 226(5):760-768. PubMed ID: 29382561
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of Continuation of Low-Molecular-Weight Heparin versus Switching to Unfractionated Heparin in the Peripartum.
    Enakpene CA; Pontarelli KN; Della Torre M
    Am J Perinatol; 2020 Feb; 37(3):304-312. PubMed ID: 30818404
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer.
    Akl EA; Rohilla S; Barba M; Sperati F; Terrenato I; Muti P; Schünemann HJ
    Cochrane Database Syst Rev; 2008 Jan; (1):CD006649. PubMed ID: 18254108
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Choosing the right heparin prophylaxis strategy in medical patients at risk for developing VTE: an evidence-based approach.
    Harrington DW
    Hosp Pract (1995); 2010 Nov; 38(4):18-28. PubMed ID: 21068523
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and safety of venous thromboembolism prophylaxis with fondaparinux or low molecular weight heparin in a large cohort of consecutive patients undergoing major orthopaedic surgery - findings from the ORTHO-TEP registry.
    Donath L; Lützner J; Werth S; Kuhlisch E; Hartmann A; Günther KP; Weiss N; Beyer-Westendorf J
    Br J Clin Pharmacol; 2012 Dec; 74(6):947-58. PubMed ID: 22515679
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk-adjusted strategies in the prevention of early arterial thrombosis following lower extremity arterial reconstruction: a comparison of unfractionated versus low molecular weight heparin.
    Winkler MS; Larena-Avellaneda A; Diener H; Kölbel T; Debus ES
    J Cardiovasc Surg (Torino); 2013 Feb; 54(1 Suppl 1):183-92. PubMed ID: 23443603
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Retrospective Analysis of Low-Molecular-Weight Heparin and Unfractionated Heparin in Pediatric Trauma Patients: A Comparative Analysis.
    Culbert MH; Hamidi M; Zeeshan M; Hanna K; Romero A; Joseph B; O'Keeffe T
    J Surg Res; 2020 May; 249():121-129. PubMed ID: 31931398
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer.
    Akl EA; Kahale L; Sperati F; Neumann I; Labedi N; Terrenato I; Barba M; Sempos EV; Muti P; Cook D; Schünemann H
    Cochrane Database Syst Rev; 2014 Jun; (6):CD009447. PubMed ID: 24966161
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and safety of a low-molecular-weight heparin and standard unfractionated heparin for prophylaxis of postoperative venous thromboembolism: European multicenter trial.
    Kakkar VV; Boeckl O; Boneu B; Bordenave L; Brehm OA; Brücke P; Coccheri S; Cohen AT; Galland F; Haas S; Jarrige J; Koppenhagen K; LeQuerrec A; Parraguette E; Prandoni P; Roder JD; Roos M; Rüschemeyer C; Siewert JR; Vinazzer H; Wenzel E
    World J Surg; 1997 Jan; 21(1):2-8; discussion 8-9. PubMed ID: 8943170
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A meta-analysis of bridging anticoagulation between low molecular weight heparin and heparin.
    Tao E; Luo YL; Tao Z; Wan L
    Medicine (Baltimore); 2020 Jan; 99(3):e18729. PubMed ID: 32011451
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anticoagulation for people with cancer and central venous catheters.
    Kahale LA; Tsolakian IG; Hakoum MB; Matar CF; Barba M; Yosuico VE; Terrenato I; Sperati F; Schünemann H; Akl EA
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006468. PubMed ID: 29856471
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interventions for preventing thrombosis in solid organ transplant recipients.
    Surianarayanan V; Hoather TJ; Tingle SJ; Thompson ER; Hanley J; Wilson CH
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD011557. PubMed ID: 33720396
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prophylactic Low-Molecular-Weight Heparin Versus Unfractionated Heparin in Spine Surgery (PLUSS): A Pilot Matched Cohort Study.
    Macki M; Haddad Y; Suryadevara R; Dabaja AL; Chedid M; Chang V;
    Neurosurgery; 2021 Nov; 89(6):1097-1103. PubMed ID: 34634115
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Unfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients.
    Junqueira DR; Perini E; Penholati RR; Carvalho MG
    Cochrane Database Syst Rev; 2012 Sep; (9):CD007557. PubMed ID: 22972111
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Weight based heparin dosing for thromboembolic disease is associated with earlier anticoagulation in surgical patients.
    Levine AR; Laliberte B; Lin H; Stan K; Ladha KS; Kaafarani HM; Lee J
    Int J Surg; 2014 Dec; 12(12):1416-9. PubMed ID: 25448664
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical experience with bemiparin.
    Abad Rico JI; Lozano Sánchez FS; Rocha E
    Drugs; 2010 Dec; 70 Suppl 2():25-33. PubMed ID: 21162607
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism.
    Robertson L; Strachan J
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD006771. PubMed ID: 28195640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.